Literature DB >> 21975347

Acetaminophen metabolism after major surgery: a greater challenge with increasing age.

G Pickering1, E Schneider, I Papet, E Pujos-Guillot, B Pereira, E Simen, C Dubray, P Schoeffler.   

Abstract

Patients undergoing major surgery represent a good model for the study of the hepatic metabolism of acetaminophen (APAP) after surgery and for the evaluation of how the detoxification process is influenced by aging. Thirty patients received intravenous APAP (1 g/6 h) for 4 days (D1-D4). Daily 24-h urinary metabolites-cysteine-APAP, mercapturate-APAP, APAP, and glucuronide and sulfate conjugates-as well as blood glutathione levels were compared with repeated-measures analysis of variance (significance, P<0.05). Between D1 and D4, cysteine-APAP increased (308±308 mg vs. 570±512 mg, P=0.005), and sulfate and glucuronide conjugates decreased (1,365±1,084 mg vs. 694±600 mg, P<0.0001 and 2,418±817 mg vs. 1,513±1,076 mg, P=0.011, respectively). Blood glutathione decreased (790±125 vs. 623±132 µmol/l, P<0.0001. These changes increased with aging. APAP disposition after major surgery shifts toward the oxidative pathways of metabolism, and this is enhanced with aging. Supplementation with sulfur-containing amino acids should be investigated further as it might minimize the effect on antioxidant defenses, especially in older persons undergoing more extensive surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21975347     DOI: 10.1038/clpt.2011.176

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients.

Authors:  Katie H Owens; Philip G M Murphy; Natalie J Medlicott; Julia Kennedy; Mathew Zacharias; Neil Curran; Sree Sreebhavan; Mark Thompson-Fawcett; David M Reith
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-05-21       Impact factor: 2.745

2.  Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103).

Authors:  Jan H Beumer; Kouros Owzar; Lionel D Lewis; Chen Jiang; Julianne L Holleran; Susan M Christner; William Blum; Steven Devine; Jonathan E Kolitz; Charles Linker; Ravi Vij; Edwin P Alyea; Richard A Larson; Mark J Ratain; Merrill J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  2014-08-28       Impact factor: 3.333

Review 3.  Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.

Authors:  Thomas M Caparrotta; Daniel J Antoine; James W Dear
Journal:  Eur J Clin Pharmacol       Date:  2017-10-24       Impact factor: 2.953

Review 4.  Paracetamol in Older People: Towards Evidence-Based Dosing?

Authors:  Paola Mian; Karel Allegaert; Isabel Spriet; Dick Tibboel; Mirko Petrovic
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

5.  Short-Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis.

Authors:  Mitchell R McGill; Laura P James; Sandra S McCullough; Jeffery H Moran; Samuel E Mathews; Eric C Peterson; Davis P Fleming; Morgan E Tripod; Joel H Vazquez; Stefanie Kennon-McGill; Horace J Spencer; Jonathan A Dranoff
Journal:  Hepatol Commun       Date:  2021-08-25

6.  Buccal acetaminophen provides fast analgesia: two randomized clinical trials in healthy volunteers.

Authors:  Gisèle Pickering; Nicolas Macian; Frédéric Libert; J Michel Cardot; Séverine Coissard; Philippe Perovitch; Marc Maury; Claude Dubray
Journal:  Drug Des Devel Ther       Date:  2014-09-26       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.